Project Details
Abstract
本計畫將對於非顯著性肝纖維化C型肝炎完成抗病毒SVR後之適切臨床追蹤時間間隔之建議，並以健保給付面及疾病整體給付(健保+自費)面，進行不同臨床追蹤時間間隔策略之成本效果分析，提供臨床追蹤策略及國家整體對於C型肝炎根除後且非顯著性肝纖維化族群之臨床追蹤策略制定參考。除此之外，本計畫將運用醫院電子病歷系統及資源，進行C型肝炎SVR後非顯著性肝纖維化個案後續罹患肝癌之風險分數計算模型，以作為追蹤資源分配之依據，並邁向個人精緻化個案管理。
Project IDs
Project ID:PC11307-1704
External Project ID:NSTC113-2314-B182-045
External Project ID:NSTC113-2314-B182-045
| Status | Active |
|---|---|
| Effective start/end date | 01/08/24 → 31/07/25 |
Keywords
- Antiviral Therapy
- Hepatitis C virus (HCV)
- Hepatocellular Carcinoma
- Sustained Viral Response (SVR)
- Retrospective Observational Cohort
- Propensity Score Analysis
- Natural history
- Surveillance interval
- Cost-effectiveness
- Machine learning
- direct-acting antiviral(DAA) therapy
- risk prediction model
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.